Thymia, a London-based online platform, offers specially designed video games that analyze speech patterns, facial expressions, and behavior to objectively measure mental health symptoms, beginning with depression. This innovative approach addresses a critical issue: millions globally remain undiagnosed for depression, and even when diagnosed, individuals often spend up to a decade searching for effective treatment. Thymia seeks to revolutionize this landscape by introducing the same level of evolution and objectivity in diagnostic tools for mental health, tracking biomarkers through its engaging platform. 

When users engage with Thymia’s specially designed games, every action—tap, swipe, or keystroke—yields insights into their mental state, including reaction times and error rates. Thymia analyzes speech to reveal a range of emotions and cognitive patterns, examining both acoustics (tone, pitch, loudness, and pauses) for emotional cues, and content (word choice and structure) for insights into cognitive states. Thymia’s AI captures and monitors various movements through device cameras, including eye-gaze patterns, facial micro-expressions, head angles, and upper body movements. This advanced video analysis allows Thymia to detect subtle behaviors often missed in face-to-face interactions. Thymias has expanded into four new continents including the UK, Europe, U.S., Spain, Brazil, Indonesia, and Nigeria.  

Thymia raised €2.7M in Seed round finding to expand the reach and capabilities of its pioneering technology. The round was led by Kodori Ventures and joined by new and existing investors including Entrepreneur first, Syndicate Room’s Access, Calm/Storm and Form Ventures.

Thymia in Three:

What problem is Thymia solving? Thymia aims to improve mental health diagnosis by using video games to objectively measure depression symptoms through linguistic biomarkets detectable through speech, and facial expressions.

What's innovative about Thymia? Thymia brings objectivity to mental health assessment by tracking mental health biomarkers through gamified tasks, rather than relying solely on self-reported questionnaires.

Who can use Thymia? Thymia provides diagnostic tools for mental health to healthcare providers, organizations, and individuals seeking depression assessments. Their primary focus is on supporting healthcare providers, payers, and employers with tailored solutions for enhanced mental health evaluation.

The company is backed by the likes of FORM Ventures, Calm/Storm Ventures, Kodori AG and was selected for Endeavor’s ScaleUp program in 2022. Emilia Molimpakis has been featured as a speaker in internationally recognized events, including the SNF Nostos Conference on Mental Health, headlined by former US President Barack Obama, Sifted Summit 2023, and others.